the clinical trial of Elias Animal Health's immunotherapy with 100 dogs diagnosed with osteosarcoma. Split into two groups, 50 received the new treatment while the other half underwent chemotherapy. The promising results are propelling further market development. Learn more on the podcast episode in our channel